BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18671966)

  • 21. Crosstalk between Src and major vault protein in epidermal growth factor-dependent cell signalling.
    Kim E; Lee S; Mian MF; Yun SU; Song M; Yi KS; Ryu SH; Suh PG
    FEBS J; 2006 Feb; 273(4):793-804. PubMed ID: 16441665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of the hyperosmotic induction of aquaporin 5 and VEGF in retinal pigment epithelial cells: involvement of NFAT5.
    Hollborn M; Vogler S; Reichenbach A; Wiedemann P; Bringmann A; Kohen L
    Mol Vis; 2015; 21():360-77. PubMed ID: 25878490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular functions of vaults and their involvement in multidrug resistance.
    Steiner E; Holzmann K; Elbling L; Micksche M; Berger W
    Curr Drug Targets; 2006 Aug; 7(8):923-34. PubMed ID: 16918321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major vault protein, in concert with constitutively photomorphogenic 1, negatively regulates c-Jun-mediated activator protein 1 transcription in mammalian cells.
    Yi C; Li S; Chen X; Wiemer EA; Wang J; Wei N; Deng XW
    Cancer Res; 2005 Jul; 65(13):5835-40. PubMed ID: 15994960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
    Huffman KE; Corey DR
    Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of the Mr 110,000 lung resistance-related protein LRP/MVP with monoclonal antibodies.
    Schroeijers AB; Scheffer GL; Reurs AW; Pijnenborg AC; Abbondanza C; Wiemer EA; Scheper RJ
    J Histochem Cytochem; 2001 Nov; 49(11):1379-85. PubMed ID: 11668191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
    van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
    Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Connection between Proliferation Rate and Temozolomide Sensitivity of Primary Glioblastoma Cell Culture and Expression of YB-1 and LRP/MVP.
    Moiseeva NI; Susova OY; Mitrofanov AA; Panteleev DY; Pavlova GV; Pustogarov NA; Stavrovskaya AA; Rybalkina EY
    Biochemistry (Mosc); 2016 Jun; 81(6):628-35. PubMed ID: 27301292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1alpha and reduces HIF-1alpha level in ACHN human renal adenocarcinoma cells.
    Iwashita K; Ikeda R; Takeda Y; Sumizawa T; Furukawa T; Yamaguchi T; Akiyama S; Yamada K
    Cancer Sci; 2010 Apr; 101(4):920-6. PubMed ID: 20175781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the major vault protein LRP in human non-small-cell lung cancer cells: activation by short-term exposure to antineoplastic drugs.
    Berger W; Elbling L; Micksche M
    Int J Cancer; 2000 Oct; 88(2):293-300. PubMed ID: 11004683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
    Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
    Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.
    Lötsch D; Steiner E; Holzmann K; Spiegl-Kreinecker S; Pirker C; Hlavaty J; Petznek H; Hegedus B; Garay T; Mohr T; Sommergruber W; Grusch M; Berger W
    Oncotarget; 2013 Nov; 4(11):1904-18. PubMed ID: 24243798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of major vault protein during the life cycle of the human parasite Schistosoma mansoni.
    Reis EV; Pereira RV; Gomes M; Jannotti-Passos LK; Baba EH; Coelho PM; Mattos AC; Couto FF; Castro-Borges W; Guerra-Sá R
    Parasitol Int; 2014 Feb; 63(1):120-6. PubMed ID: 24148287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
    van Vliet EA; Aronica E; Redeker S; Gorter JA
    Epilepsia; 2004 Dec; 45(12):1506-16. PubMed ID: 15571508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Depletion of major vault protein increases doxorubicin sensitivity and nuclear accumulation and disrupts its sequestration in lysosomes.
    Herlevsen M; Oxford G; Owens CR; Conaway M; Theodorescu D
    Mol Cancer Ther; 2007 Jun; 6(6):1804-13. PubMed ID: 17575109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells.
    Xiao YS; Zeng D; Liang YK; Wu Y; Li MF; Qi YZ; Wei XL; Huang WH; Chen M; Zhang GJ
    Cancer Lett; 2019 Jan; 440-441():156-167. PubMed ID: 30336197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
    Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
    Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and zygotes.
    Sutovsky P; Manandhar G; Laurincik J; Letko J; Caamaño JN; Day BN; Lai L; Prather RS; Sharpe-Timms KL; Zimmer R; Sutovsky M
    Reproduction; 2005 Mar; 129(3):269-82. PubMed ID: 15749954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution structure of a two-repeat fragment of major vault protein.
    Kozlov G; Vavelyuk O; Minailiuc O; Banville D; Gehring K; Ekiel I
    J Mol Biol; 2006 Feb; 356(2):444-52. PubMed ID: 16373071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lupulone triggers p38 MAPK-controlled activation of p53 and of the TRAIL receptor apoptotic pathway in human colon cancer-derived metastatic cells.
    Lamy V; Bousserouel S; Gossé F; Minker C; Lobstein A; Raul F
    Oncol Rep; 2011 Jul; 26(1):109-14. PubMed ID: 21519792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.